National news & research

The U.S. Department of Veterans Affairs has launched a new MDMA-assisted therapy clinical trial focused on veterans with PTSD and trauma-related conditions. The initiative reflects growing interest in evidence-based psychedelic-assisted therapies and broader efforts to expand innovative mental health treatment options for veterans and other trauma survivors.

Read the full article

The proposal would create a state initiative for clinical studies involving ibogaine and psilocybin

Read the full order here

Press release: Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls

Press release: President Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans

A White House executive order on psychedelics, signed by President Donald Trump on Saturday, aims to speed up research on drugs like psilocybin, MDMA and ibogaine, helping to legitimize an industry that’s long lived largely underground.

Executive Order: Accelerating Medical Treatments for Serious Mental Illness Fact Sheet: President Donald J. Trump is Accelerating Medical Treatments for Serious Mental Illness